risperidone has been researched along with Cholestasis, Intrahepatic in 1 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Cholestasis, Intrahepatic: Impairment of bile flow due to injury to the HEPATOCYTES; BILE CANALICULI; or the intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Legaz Huidobro, ML | 1 |
| González Carro, P | 1 |
| Pérez Roldán, F | 1 |
| Soto Fernández, S | 1 |
| de Pedro Esteban, A | 1 |
| Cuesta Domínguez, R | 1 |
1 other study available for risperidone and Cholestasis, Intrahepatic
| Article | Year |
|---|---|
[Autoimmune hepatitis after risperidone-induced cholestatic hepatitis].
Topics: Adult; Antipsychotic Agents; Cholestasis, Intrahepatic; Female; Hepatitis, Autoimmune; Humans; Rispe | 2005 |